New Delhi, Sep 02 (ANI): The Drug Controller General of India (DCGI) on Wednesday informed that the Phase 3 trial of Hyderabad-based Biological E Limited for its anti-COVID shots is underway. Member-Health, NITI Aayog, Dr VK Paul said, “Phase 3 trial work of Biological E going on. Stockpile being produced. We should wait for results, we hope it'll be in next month or 2. They've made broad commitment that they'll supply significant amount by year-end”.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting